Psychemedics Revenue 2010-2024 | PMD

Psychemedics revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Psychemedics Annual Revenue
(Millions of US $)
2023 $22
2022 $25
2021 $25
2020 $21
2019 $38
2018 $43
2017 $40
2016 $39
2015 $27
2014 $29
2013 $27
2012 $25
2011 $24
2010 $20
2009 $17
Psychemedics Quarterly Revenue
(Millions of US $)
2024-09-30 $5
2024-06-30 $5
2024-03-31 $5
2023-12-31 $5
2023-09-30 $6
2023-06-30 $6
2023-03-31 $6
2022-12-31 $6
2022-09-30 $7
2022-06-30 $7
2022-03-31 $7
2021-12-31 $6
2021-09-30 $7
2021-06-30 $6
2021-03-31 $6
2020-12-31 $5
2020-09-30 $5
2020-06-30 $3
2020-03-31 $8
2019-12-31 $9
2019-09-30 $10
2019-06-30 $9
2019-03-31 $10
2018-12-31 $10
2018-09-30 $11
2018-06-30 $11
2018-03-31 $11
2017-12-31 $10
2017-09-30 $10
2017-06-30 $10
2017-03-31 $10
2016-12-31 $11
2016-09-30 $12
2016-06-30 $10
2016-03-31 $7
2015-12-31 $6
2015-09-30 $7
2015-06-30 $7
2015-03-31 $7
2014-12-31 $7
2014-09-30 $8
2014-06-30 $8
2014-03-31 $7
2013-12-31 $6
2013-09-30 $7
2013-06-30 $7
2013-03-31 $6
2012-12-31 $6
2012-09-30 $6
2012-06-30 $7
2012-03-31 $6
2011-12-31 $6
2011-09-30 $6
2011-06-30 $6
2011-03-31 $6
2010-12-31 $5
2010-09-30 $5
2010-06-30 $5
2010-03-31 $4
2009-12-31 $4
2009-09-30 $5
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
RadNet (RDNT) United States $4.764B 105.51
LifeStance Health (LFST) United States $3.053B 0.00
Amedisys (AMED) United States $3.017B 21.47
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
U.S Physical Therapy (USPH) United States $1.324B 34.81
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Atai Life Sciences (ATAI) Germany $0.356B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00